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Dear Editor,
The manuscript entitled BCalcium plus vitamin D supplemen-
tation and risk of fractures: an updated meta-analysis from the
National Osteoporosis Foundation [1]^ sought to update a
former AHRQ evidence report [2]. The study was commis-
sioned by the NOF to inform the organization, since a signif-
icant controversy exists regarding the effectiveness of supple-
mental calcium and vitamin D to prevent fractures. We chose
to use the per protocol analyses data across studies to be con-
sistent with the two former AHRQ evidence reports [2, 3] and
to assess the actual effect of supplementation among individ-
uals who were adherent throughout the duration of various
studies included in the meta-analysis. It is challenging for a
public-health organization to formulate accurate guidance
solely from intention to treat analyses, where half of the pop-
ulation in some cases either dropped out or were not adherent
by the end of the study. In both former AHRQ evidence re-
ports [2, 3], adherence to the interventions were considered as
part of the risk of bias assessment and analysis as adherence
was important to estimate the actual doses received by the
study participants for the purpose of deriving dietary reference
intake (DRI) values; we chose for the same reason to continue
this type of analysis. Though others may disagree with the
decision to use per protocol analysis, alteration of the number
of fractures among the studies present in Table 1 of Weaver
et al. (2016) [1] and/or substitution with intention to treat
analyses data does not influence the pooled relative risk or
outcomes of the NOF meta-analysis. It is standard protocol
for bodies such as the AHRQ to exclude studies in a non-
English language; it is unclear from the English abstract if
the study [4] mentioned by Bolland and colleagues in their
letter was designed to assess fracture outcomes. It also is un-
clear if the participants in the latter Chapuy et al. (1994) one-
page narrative manuscript [5] were still randomized to the
original study protocol (a large number of individuals are no
longer present in the study). Since both studies by Chapuy and
others show similar beneficial effects of supplemental calcium
and vitamin D, it is unlikely that substitution of the Chapuy
et al. (1992) [6] data with the Chapuy et al. (1994) [5] data will
affect the pooled relative risk and/or outcomes of the NOF
meta-analysis.
The NOF utilized (and continues to apply) rigorous basic
elements of process when accepting commercial support. This
process is modeled based on recommendations from the 2009
US Institute ofMedicine (IOM) report onConflict of Interest in
Medical Research, Education, and Practice [7], as well as the
processes of the US Preventive Services Task Force [8] and
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ACCME Standards for Commercial Support [9]. Furthermore,
it is the internal process of the NOF that all contracted univer-
sities or consulting groups and expert volunteers serving as
authors on any particular manuscript be blinded of the funding
source until the manuscript is submitted for publication. The
NOF is willing to share all documented communications with
funding organizations for any of its activities. Data from the
NOF meta-analysis [1] are publically available.
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